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pathogenesis of bloodstream infection
Caroline Marshall* and Emma McBrydeAbstract
Background: Staphylococcus aureus (SA) colonisation is associated with development of bloodstream infection
(BSI), with the majority of colonising and infecting strains identical by pulsed-field gel electrophoresis (PFGE).
We examined SA colonisation in patients with SABSI to delineate better the relationship between the two.
Methods: Patients with SABSI were swabbed in the nose, throat, groin, axilla and rectum. Isolates were typed
using PFGE. Logistic regression was performed to determine factors associated with positive swabs.
Results: 79 patients with SABSI had swabs taken. 46 (58%) had ≥ 1 screening swab positive for S. aureus; of
these 37 (80%) were in the nose, 11 (24%) in the throat, 12 (26%) in the groin, 11 (24%) in the axilla and 8
(17%) in the rectum. On multivariate analysis, days from blood culture to screening swabs (OR 0.5, 95% CI
0.32-0.78, P = 0.003) and methicillin resistance (OR 9.5, 95% CI 1.07-84.73, P = 0.04) were associated with having
positive swabs. Of 46 participants who had a blood sample and 1 other sample subtyped, 33 (72%, 95% CI
57-84%) had all identical subtypes, 1 (2%) had subtypes varying by 1–3 bands and 12 (26%) had subtypes ≥ 3 bands
different. 30/36 (83%) blood-nose pairs were identical.
Conclusion: Overall, 58% of patients with SABSI had positive screening swabs. Of these, only 80% had a positive
nose swab ie less than half (37/79, 47%) of all SABSI patients were nasally colonised. This may explain why
nasal mupirocin alone has not been effective in preventing SA infection. Measures to eradicate non-nasal carriage
should also be included.
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Colonisation with Staphylococcus aureus has a well-
recognised association with development of infection, in-
cluding surgical site and blood stream infections [1,2].
Evidence to confirm this as a causal link has been pro-
vided by several studies showing that the majority of
colonising and infecting strains are identical when typed
using pulsed-field gel electrophoresis (PFGE) [3,4]. How-
ever, the detail of these studies indicates that the pro-
portion of participants with no bacteraemia and no
colonisation is either high [4] or not given [3]. It is known
that individuals can be colonised with S. aureus in sites
other than the nose, including the throat, axilla, groin and
rectum and it is thought that these non-nasal sites might* Correspondence: caroline.marshall@mh.org.au
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article, unless otherwise stated.be important in the pathogenesis of infection [5] and also
the inconsistent success of intra-nasal mupirocin in pre-
venting infections [1,6]. Gastro-intestinal carriage in par-
ticular has been suggested as an important reservoir for
S. aureus carriage [7,8].
In this study, we swabbed patients with S. aureus
blood stream infection (SABSI) in multiple sites to deter-
mine what proportion was colonised at any site, which
sites were most often colonised and whether gastrointes-
tinal carriage in particular was important and whether the
colonising and infecting isolates were the same.Methods
The study took place at Melbourne Health between 14/
05/08 and 11/09/10. The majority of patients were re-
cruited from the Royal Melbourne Hospital (RMH), with
a small number from another affiliated hospital. RMH isd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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beds and a 28 bed intensive care unit.
The number of patients needed for this study was cal-
culated by calculating confidence intervals around the
possible proportions of patients with S. aureus carriage
at a particular site. We chose a sample size of 100 bac-
teraemic patients to ensure the standard deviation of the
estimated proportions was 5% or less.
Patients with blood cultures positive for SA were noti-
fied to the researcher by the microbiology laboratory.
Many were unable to participate in the study because of
inability to give consent resulting from illness severity,
cognitive impairment or lack of English proficiency with
no interpreter available. Patients with neutropenia were
excluded because they were unable to have rectal swabs
taken because of the potential risk of bacterial transloca-
tion [9]. Study participants were swabbed in the nose,
throat, groin, axilla and rectum with dry swabs as soon as
possible after preliminary blood culture results were avail-
able. Data were collected on patient demographics, length
of hospital stay prior to blood cultures and screening
swabs, intensive care unit admission and intubation status,
use of enteric feeding tube, antibiotic and antacid use and
use of enteric or topical antibiotics at the time of blood
cultures. The likely source of the blood stream infection
was determined from the patient notes and if the patient
had MRSA, determination of likely community or health-
care acquisition was made. Decolonisation with mupirocin
or chlorhexidine body washes was not used on any pa-
tients in the hospital at that time.
Swabs were plated onto NC (nalidixic acid and colistin
sulphate) plates up to June 2008. SAID chromogenic
agar (Biomerieux) plates were then used until the end of
September 2009, after which CNA (Colombia horse blood,
naladixic acid and Colimycin) plates (Oxoid) were used.
Presumptive staphylococcal isolates were tested using
latex agglutination and sensitivities were determined on
the Vitek 2 analyser. Identification was performed using a
DNAse plate, an ORSA plate, an Oxacillin, Esculin plate
and a 6.5% salt plate.
Isolates were typed by PFGE using a modified method
previously reported [10]. The blood isolate was desig-
nated the index subtype and those 1–3 bands different
were designated 1a, 1b etc. Those greater than three bands
different were designated as a different subtype ie type 2,
3 etc. [11]. Not all isolates were available for subtyping,
but denominators are given in the results section.
Data were analysed using Stata version 9 (Stata Corp.,
College Station, TX, US). Descriptive analysis was per-
formed and 95% confidence intervals calculated around
proportions. Univariate logistic regression was performed
to determine associations between predictor variables and
the outcome variable (positive swabs versus no positive
swabs). Stepwise multivariate regression was performedusing a P value of 0.1 for entry and a P value of 0.2 for re-
moval from the model.
This study was approved by the Melbourne Health
Human Research Ethics Committee and written consent
was obtained from the participant or responsible person
if the participant was unable to provide consent.
Results
There were 78 patients with S. aureus BSI entered in the
study, one twice. This was counted as separate entries
into the study as the episodes of blood stream infection
were over three months apart, making a total of 79 study
entries. Patient details were unavailable for the three pa-
tients from the affiliated hospital (Figure 1). All participants
had swabs taken at all sites. The average age of participants
was 60 (median 61, range 19–88) years. Sixty-four (81%)
participants were male and 16 (20%) were in the intensive
care unit.
Table 1 shows the susceptibility of blood isolates and
the timing of isolation. Of the MRSA isolates, four were
sensitive to erythromycin, suggesting a community ac-
quired strain although one had its onset ten days after
hospital admission. Three of the isolates that were methi-
cillin resistant and erythromycin sensitive, however, had
risk factors for healthcare association (a history of either
MRSA colonisation or infection in the previous year, hos-
pitalisation, surgery, dialysis or residence in a long-term
care facility within the previous year or an indwelling
catheter or percutaneous device at the time of the positive
blood culture).
The likely primary source of the BSI is shown in Table 2.
The median number of days from the first positive
blood culture to the date of screening swabs was three
(range 1–8). Sixty-four (81%) of participants had screen-
ing swabs performed within four days of their first posi-
tive blood culture. Forty-six participants (58%, 95% CI
47–69) had at least one screening swab positive for S.
aureus. Table 3 shows the proportion of screening sites
positive for S. aureus. The most common combinations of
sites were nose-throat, nose-axilla and nose-groin with
three each and all sites and throat-groin being positive in
two participants each.
Forty-two (95.5%) patients with positive screening swabs
were on antibiotics at the time of screening and all 33 pa-
tients with negative screening swabs were on antibiotics at
the time of the screening swabs (P = 0.22).
Logistic regression was performed to determine any asso-
ciations between the outcome variable (any positive swabs
versus no positive swabs) and the predictor variables (age,
gender, type of plate used [either NC or CNA vs. chromo-
genic agar], days from blood cultures to screening swabs,
methicillin resistance [vs. methicillin sensitivity] and any
antibiotics at the time of the screening swabs). On univari-
ate analysis, age (OR 1.03, 95% CI 1.0-1.06, P = 0.048),
Figure 1 Flow diagram of patients in study. *Patients only included once and patients from other institution excluded.
Table 2 Likely source of blood stream isolate
Source Number (n = 79) Percentage
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95% CI 0.36-0.79, P = 0.002) and methicillin resistance
(OR 10.1, 95% CI 1.23-82.33, P = 0.03) were found to be
associated with having any positive swabs. On multivariate
regression, age was no longer significant (OR 1.03, 95% CI
1.00-1.06, P = 0.6) but days from blood culture to screen-
ing swabs remained significant (OR 0.5, 95% CI 0.32-0.78,
P = 0.003) as did methicillin resistance (OR 9.5, 95% CI
1.06-84.73, P = 0.04).
Forty-six participants had a S. aureus isolate from
blood and one or more screening sites subtyped using
PFGE. Twenty (44%) had two different samples, 18 (39%)




Number isolated before or
within 2 days of hospital
admission (n = 53)
Penicillin sensitive
S. aureus (PSSA)
12 (15%) 10 (83%)
Methicillin sensitive
S. aureus (MSSA)
55 (70%) 38 (70%)
Methicillin resistant
S. aureus (MRSA)
12 (15%) 5 (45%)(4%) had six samples submitted. Thirty-three (72%) had
all identical subtypes, one (2%) had subtypes varying by
one to three bands and 12 (26%) had samples with sub-
types deviating greater than three bands. In 11 of the 12
patients with different subtypes, only one of the samples
differed from all the others. In the one exception, the par-
ticipant had a blood and groin isolate that were identical,
axilla and rectal isolates that were identical to each other
but more than three bands different from the blood andAV fistula/graft for dialysis 10 12.99
Bone or joint infection 5 6.49
Endocarditis 11 14.29
Intravascular line 30 38.96
Pneumonia 1 1.30
Skin or soft tissue 5 6.49
Surgical site infection 6 7.79
No source identified 7 9.09
Other 2 2.60
AV - arteriovenous.
Table 3 Screening sites positive for S. aureus
Site Number of participants positive
in this site as a proportion of
all patients with BSI (%) (n = 78)
Number of participants with positive SA
swabs in this site as a proportion of all




with SA positive swabs in
this site only (%) (n = 46)
Nose 37 (47%) 37 (80%) 69-92 21 (46%)
Throat 11 (14%) 11 (24%) 11-37 3 (4%)
Groin 12 (15%) 12 (26%) 12-39 1 (1%)
Axilla 11 (14%) 11 (24%) 11-37 1 (1%)
Rectum 8 (10%) 8 (17%) 6-29 0
Numbers add up to greater than 100% as patients could be positive in more than one site.
BSI – blood stream infection, SA – Staphylococcus aureus.
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three bands different from each of the other two subtypes.
Of the 36 participants that had at least a blood and nose
isolate typed, six (17%, 95% CI 6-33%) were greater than
three bands different. Of the seven patients that had blood
and rectal isolates subtyped, two differed by more than
three bands.
Discussion
This study found that only 58% of patients with a SABSI
had a screening swab that was positive at any site (nose,
throat, groin, axilla, rectum) and of these, 80% had a
positive nose swab. Overall, this means that less than
half (37/79, 47%) of all patients with SABSI in this study
were found to be colonised in the nose. Of the 36 blood-
nose pairs that were subtyped, 30 (83%) had identical nose
and bloodstream isolates by PFGE. Patients with MRSA
were more likely to have positive screening swabs, suggest-
ing that there may be an intrinsic difference in the propen-
sity for MRSA to colonise body sites compared with MSSA
or that the patients with MRSA may have been sicker or
hospitalised longer and thus were more likely to develop
multisite colonisation. Another explanation may be that
once colonised, MRSA are more likely to invade.
In several studies, infecting and colonising isolates have
been typed and most isolates have been found to be iden-
tical. In one study, 40/3420 prospectively followed nasal
S. aureus carriers developed nosocomial SABSI compared
with 41/10558 non-nasal carriers [4]. Typing using PFGE
showed that 32/40 (80%) blood isolates were identical to
the nasal strain. However, it is worth noting that 41/81
(51%) of participants with SABSI were not nasally colo-
nised and 49/80 (61%) bacteraemic patients were not nas-
ally colonised with the same S. aureus strain, which are
almost identical to the figures in our study. That study did
not swab non-nasal sites, unlike our study where it was
found that 9/42 (20%) of the participants not colonised in
the nose were colonised at other sites - these would have
been classified as “non-nasal carriers” in that study. These
“non-carriers” were found to have a higher mortality from
SABSI than the “nasal carriers”; one could speculatewhether patients with non-nasal carriage are different
from nasal carriers, making it especially important to de-
vise effective decolonisation strategies for non-nasal sites,
such as chlorhexidine body washes.
In another study, nasal and blood isolates were typed
using PFGE and were found to be identical in 180/219
(82.2%, 95% CI 76.4-87.1) [3]. If areas other than the
nose were included, 94.3% were identical. However, the
total number of bacteraemic patients who were screened
for nasal carriage and the proportion of bacteraemic pa-
tients who were nasal carriers of S. aureus were not re-
ported. In this study, although nasal swabs were reported
to be taken “immediately after the isolation of S. aureus
from the blood”, no data were collected on the actual time
to swab taking and whether the patient was already on an-
tibiotics at the time of swab collection.
Non-nasal colonisation is well recognised for S. aureus,
including MRSA, in many cases without concurrent nasal
colonisation [12]. These non-nasal sites have been postu-
lated to be important in the pathogenesis of infection
[7,8], as a reservoir for transmission [13] and as a potential
explanation for failure of nasal decolonisation in prevent-
ing infection with S. aureus [14]. The throat has been
found to be an important site of colonisation, particularly
for hospitalised patients with MRSA [15]. The gastro-
intestinal tract has also been recognised as a reservoir for
S. aureus [16,17,7,18-22], with studies showing increased
sensitivity for detection of MRSA when rectal swabs were
included [23], rectal colonization without nasal carriage
[8,18,24] and increased chance of developing S. aureus in-
fection in rectal carriers [7,8].
We have previously found that 6.3% and 37.5% of
methicillin-sensitive (MSSA) and methicillin-resistant
S. aureus (MRSA) carriers in an ICU population were
colonised in the rectum [25]. In this study, swabbing the
nose, throat and rectum and the nose, throat and axilla
were the most sensitive combination of sites for detecting
MRSA and MSSA respectively. Although groin/perineal
swabs have been assumed to be synonymous with rectal
carriage [26], we found that 3/8 rectal carriers were nega-
tive in groin swabs and 7/12 with positive groin swabs had
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interchangeably. In the current study, we found that 17% of
participants were colonised in the rectum.
Because of the strong association of nasal carriage of
S. aureus with development of infection, it could be rea-
sonably assumed that eradication of nasal carriage would
reduce the incidence of infection. However, several major
randomised double-blind placebo-controlled trials have
not shown that intranasal mupirocin prevented surgical
site infection or non-surgical site infection [1,6,27]. A ran-
domised placebo-controlled trial using intranasal mupiro-
cin and chlorhexidine body washes for eradication of
endemic MRSA colonisation at multiple body sites in ICU
patients showed there was no significant difference in
eradication of MRSA at any site or in the rate of MRSA
infection. Risk factors for failure to eradicate MRSA in-
cluded multi-site MRSA carriage [28].
Another more recent study showed that use of nasal
mupirocin and daily chlorhexidine body washes prevented
surgical and non-surgical site infections in S. aureus carriers
identified using rapid detection methods [29]. In other un-
controlled studies, mupirocin has been used successfully to
eradicate carriage of S. aureus but recolonisation has been
a problem [5,12,24]. Other hidden reservoirs, such as the
throat and gastrointestinal tract, could contribute to the
failure of mupirocin to completely prevent infection [5].
Enteral vancomycin has been used in several uncontrolled
trials with consequent reductions in MRSA carriage and
infection in the outbreak and the endemic setting [19,30].
Although concerns about the development of resistance
prevent this from becoming a widespread intervention, it
suggests that gastrointestinal carriage may be important.
Although this study included a heterogeneous mixture
of patients with MSSA and MRSA and both community
and healthcare associated infections, we have found re-
sults consistent with other studies. It would have been
ideal to swab patients and follow them up prospectively
to determine development of BSI, but the large numbers
(several thousand) required to conduct such a cohort
study [4] was not feasible. Other studies have based their
findings on similar methodology of screening patients
after results were available [3]. We tried to swab patients
as soon as possible after results were available.
Antibiotic treatment may have decreased the yield of de-
tecting colonisation, although in the multivariable analysis,
this was not a significant predictor of whether screening
swabs were positive or not. However, carriage was still de-
tected in many patients on antibiotics suggesting only vari-
able efficacy in eliminating carriage using antibiotics, and
this is consistent with other studies where S. aureus was
still able to be cultured from screening swabs from many
patients on antibiotics [31].
Some studies have found using flocked swabs and pre-
moistened swabs increases the yield [32] but this has notbeen found universally [33,34]. We also did not use broth
enrichment when processing screening swabs which also
may have decrease the yield. Interestingly, the published
studies examining colonisation and bacteraemia did not re-
port how screening swabs were processed or whether pa-
tients were on antibiotics at the time of taking swabs [3,4].
Conclusion
In conclusion, this study confirms that patients with SABSI
are colonised in multiple sites, including the gastrointes-
tinal tract. Consistent with other studies, we also found
that the majority of patients with blood stream infection
were not colonised with the same strain in the nose, pos-
sibly explaining why nasal mupirocin alone has not been
shown to be effective in the prevention of infection. Mea-
sures to eradicate carriage at these non-nasal sites in
addition to nasal sites, such as chlorhexidine body washes,
may be considered to prevent infection, especially for
patients with MRSA. Further research into decolonisation
of non-nasal and non-skin sites, especially the gastrointes-
tinal tract, is also needed, as eradication at these sites may
provide even more effective infection prevention strategies.
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